Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • Exagen's Change in Account Payables rose 18543.05% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 43228.2%. This contributed to the annual value of $308000.0 for FY2024, which is 35970.15% up from last year.
  • Per Exagen's latest filing, its Change in Account Payables stood at $1.0 million for Q3 2025, which was up 18543.05% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Exagen's Change in Account Payables peaked at $2.3 million during Q4 2024, and registered a low of -$1.8 million during Q2 2025.
  • Its 5-year average for Change in Account Payables is $4000.0, with a median of $231000.0 in 2025.
  • Per our database at Business Quant, Exagen's Change in Account Payables surged by 103062.5% in 2023 and then crashed by 46829.27% in 2024.
  • Over the past 5 years, Exagen's Change in Account Payables (Quarter) stood at $430000.0 in 2021, then tumbled by 137.21% to -$160000.0 in 2022, then soared by 1030.62% to $1.5 million in 2023, then soared by 56.88% to $2.3 million in 2024, then tumbled by 55.82% to $1.0 million in 2025.
  • Its Change in Account Payables stands at $1.0 million for Q3 2025, versus -$1.8 million for Q2 2025 and $231000.0 for Q1 2025.